In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CALCIUM POLYSTYRENE SULPHONATE Drug Master File in Korea (CALCIUM POLYSTYRENE SULPHONATE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CALCIUM POLYSTYRENE SULPHONATE. The MFDS reviews the CALCIUM POLYSTYRENE SULPHONATE KDMF as part of the drug registration process and uses the information provided in the CALCIUM POLYSTYRENE SULPHONATE KDMF to evaluate the safety and efficacy of the drug.
After submitting a CALCIUM POLYSTYRENE SULPHONATE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CALCIUM POLYSTYRENE SULPHONATE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CALCIUM POLYSTYRENE SULPHONATE suppliers with KDMF on PharmaCompass.